Ralf Rosskamp
2018
In 2018, Ralf Rosskamp earned a total compensation of $1M as Chief Medical Officer at Dicerna Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,066 |
|---|---|
| Option Awards | $370,755 |
| Salary | $443,331 |
| Other | $18,592 |
| Total | $1,027,744 |
Rosskamp received $443.3K in salary, accounting for 43% of the total pay in 2018.
Rosskamp also received $195.1K in non-equity incentive plan, $370.8K in option awards and $18.6K in other compensation.
Rankings
In 2018, Ralf Rosskamp's compensation ranked 9,084th out of 14,244 executives tracked by ExecPay. In other words, Rosskamp earned more than 36.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,084 out of 14,244 | 36th |
Division Manufacturing | 3,617 out of 5,762 | 37th |
Major group Chemicals And Allied Products | 1,363 out of 2,125 | 36th |
Industry group Drugs | 1,144 out of 1,814 | 37th |
Industry Pharmaceutical Preparations | 890 out of 1,388 | 36th |
Source: SEC filing on April 22, 2020.
Rosskamp's colleagues
We found three more compensation records of executives who worked with Ralf Rosskamp at Dicerna Pharmaceuticals in 2018.